Innospec Inc. — FY2013 Form 10-K
Business context and reporting period. This annual filing covers the fiscal year ended December 31, 2013; the filing is not limited to fourth-quarter results. Innospec develops and sells fuel additives, oilfield chemicals, personal care and fragrance ingredients, and other specialty chemicals. Its reporting segments are Fuel Specialties (including Oilfield Specialties), Performance Chemicals, and Octane Additives. Management characterized 2013 performance as close to expectations: growth businesses advanced while Octane Additives declined with the transition to unleaded gasoline.
Key financial metrics
| Metric | FY2013 | FY2012 |
|---|---|---|
| Net sales | $818.8 million | $776.4 million |
| Gross profit / gross margin | $255.2 million / 31.2% | $236.4 million / 30.4% |
| Operating income / operating margin | $90.6 million / 11.1% | $96.5 million / 12.4% |
| Net income | $77.8 million | $66.9 million |
| Diluted EPS | $3.22 | $2.81 |
| Operating cash flow | $61.3 million | $61.3 million |
| Cash, cash equivalents and short-term investments, year-end | $86.8 million | $27.5 million |
| Total debt, year-end | $148.0 million | $30.0 million |
- Segment sales: Fuel Specialties $567.4 million, up 8%; Performance Chemicals $192.4 million, up 7%; Octane Additives $59.0 million, down 15%. Segment operating income was $92.7 million, $23.6 million and $21.5 million, respectively.
- Fuel Specialties gross margin increased to 31.9% from 30.1%; Performance Chemicals margin edged down to 24.1% from 24.4%; Octane Additives margin declined to 47.1% from 48.7%.
- Operating cash flow was unchanged year over year. Investing used $116.1 million, including $94.4 million for business combinations; financing provided $112.8 million, primarily reflecting borrowing.
- Year-end current ratio was 2.6, versus 2.0. Management reported net debt of $61.2 million. Adjusted working capital, a company-defined non-GAAP measure, rose to $163.7 million from $128.7 million.
- GAAP effective tax rate declined to 16.2% from 28.3%. The company’s adjusted effective tax rate was 15.9% versus 20.2%.
Material changes versus the prior year
- Revenue rose 5%, and gross profit rose 8%, led by Fuel Specialties and Performance Chemicals. Operating income nevertheless fell about 6% as operating expenses increased 18% to $163.1 million, including acquisition-related costs, higher personnel and R&D costs, and corporate expenses.
- Net income increased despite lower operating income, aided by a $4.1 million gain in other net income (versus a $2.0 million expense in 2012) and lower income-tax expense. Higher borrowing increased net interest expense.
- In 2013, Innospec acquired Bachman for approximately $60.8 million in cash and stock, and acquired Chemsil and Chemtec for approximately $57.4 million in cash and stock. These acquisitions expanded oilfield specialties and personal care. Together, the acquired businesses contributed $21.5 million of 2013 revenue after acquisition.
- Debt rose substantially to fund acquisitions. The revolving facility was amended, increasing its stated availability from $100 million to $150 million, with a further $30 million committed under an option for additional commitments.
- The company identified an error in its UK pension-plan asset-value calculation and revised prior-year financial statements for immaterial, non-cash pension expense errors. Revised net income was lower by $1.8 million for 2011 and $1.4 million for 2012.
- The $2.00 per-share dividend paid in 2012 was a special distribution; the 2013 declared dividend was $0.50 per share.
Outlook, risks and unusual items
- Management expected to fund operations for at least the next 12 months through operating cash flow and the revolving facility, and expected compliance with debt covenants over that period. No specific sales or earnings guidance is provided in the supplied filing text. Management said the information-system investment was expected to add value in 2014.
- The credit facility requires net debt to EBITDA of no more than 2.5:1 and EBITDA to net interest of at least 4.0:1. Debt is primarily floating-rate; management estimated a 1% rate change would affect annual pre-tax income and cash flow by approximately $0.6 million on a net basis.
- Environmental remediation provisions were $31.4 million, principally related to Ellesmere Port, the UK TEL site. Timing and costs remain uncertain; estimated contractual remediation payments total $31.4 million, including $6.2 million due in 2014.
- The UK defined-benefit pension plan had a projected benefit obligation of $819.8 million and assets of $790.3 million at year-end. Planned pension funding commitments total $50.6 million; management estimated 2014 contributions of $11.4 million. Pension costs and funding are sensitive to discount-rate, inflation and investment assumptions.
- A UK lawsuit by JAG seeks up to $42.3 million, inclusive of costs, for alleged lost profits. Innospec disputes the claim and intends to defend it; the filing does not provide a clear estimated loss or indicate that a liability was recorded for this claim.
- Other notable exposures include raw-material and energy price volatility, currency movements, customer concentration (Shell represented 10% of sales), acquisition integration, regulatory and international-compliance risks, and possible disruption from manufacturing or IT-system failures. The company estimated REACH compliance costs of approximately $2 million over three years.
- Auditors issued an unqualified opinion on the financial statements and internal control over financial reporting. Management and the auditor excluded the acquired Chemsil, Chemtec and Bachman businesses from the internal-control assessment; these businesses represented $126.0 million of assets and $21.5 million of revenue in the consolidated statements.
Important facts for investors to verify
- Whether acquired businesses deliver expected growth and returns, and how acquisition-related costs and amortization affect future margins and earnings.
- Debt reduction, available facility capacity, covenant headroom and refinancing exposure, particularly with $142.0 million drawn under a facility maturing in 2016.
- Cash conversion and working-capital trends, including increased receivables and inventories and higher days’ sales outstanding in both growth segments.
- The assumptions, funding schedule and sensitivity of the UK pension plan, as well as the adequacy and timing of environmental remediation provisions.
- Developments in the JAG litigation, uncertain tax positions and any other legal or regulatory contingencies.
- Whether integration of the acquired companies and further deployment of the new information system proceed as planned; the acquired companies were excluded from the year-end internal-control assessment.